Annotations: 6DVU

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	PF04691	e6dvuA1	A: alpha bundles	X: C-terminal helical domain of alanine-tRNA ligase (From Homology)	H: C-terminal helical domain of alanine-tRNA ligase	T: Eukaryotic C-Ala helical domain	F: PF04691	ECOD (1.6)
B	PF04691	e6dvuB1	A: alpha bundles	X: C-terminal helical domain of alanine-tRNA ligase (From Homology)	H: C-terminal helical domain of alanine-tRNA ligase	T: Eukaryotic C-Ala helical domain	F: PF04691	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B	PF04691	Apolipoprotein C-I (ApoC-1) (ApoC-I)	Apolipoprotein C-I (ApoC-1)	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B	Apolipoprotein C-I	fatty acid binding organic acid binding binding ion binding anion binding lipid binding carboxylic acid binding monocarboxylic acid binding small molecule binding enzyme regulator activity molecular function inhibitor activity molecular function regulator activity enzyme inhibitor activity lipase inhibitor activity fatty acid binding organic acid binding binding ion binding anion binding lipid binding carboxylic acid binding monocarboxylic acid binding small molecule binding enzyme regulator activity molecular function inhibitor activity molecular function regulator activity enzyme inhibitor activity lipase inhibitor activity cation binding phosphatidylcholine binding phospholipid binding quaternary ammonium group binding phospholipase inhibitor activity enzyme activator activity molecular function activator activity phosphatidylcholine-sterol O-acyltransferase activator activity	regulation of cellular process regulation of lipid metabolic process glycerolipid catabolic process negative regulation of biological process organophosphate catabolic process cellular lipid catabolic process negative regulation of cellular metabolic process regulation of primary metabolic process cellular catabolic process regulation of phosphate metabolic process phosphate-containing compound metabolic process phosphatidylcholine metabolic process phosphorus metabolic process negative regulation of lipid catabolic process regulation of cellular process regulation of lipid metabolic process glycerolipid catabolic process negative regulation of biological process organophosphate catabolic process cellular lipid catabolic process negative regulation of cellular metabolic process regulation of primary metabolic process cellular catabolic process regulation of phosphate metabolic process phosphate-containing compound metabolic process phosphatidylcholine metabolic process phosphorus metabolic process negative regulation of lipid catabolic process organonitrogen compound catabolic process regulation of phospholipid catabolic process regulation of biological process cellular metabolic process negative regulation of metabolic process primary metabolic process regulation of cellular metabolic process regulation of lipid catabolic process cellular lipid metabolic process regulation of phosphatidylcholine catabolic process metabolic process glycerolipid metabolic process glycerophospholipid catabolic process regulation of phosphorus metabolic process regulation of metabolic process negative regulation of lipid metabolic process negative regulation of cellular catabolic process catabolic process phospholipid catabolic process glycerophospholipid metabolic process negative regulation of phosphate metabolic process phospholipid metabolic process organic substance metabolic process negative regulation of phosphatidylcholine catabolic process negative regulation of cellular process negative regulation of catabolic process organonitrogen compound metabolic process lipid catabolic process biological regulation regulation of phosphatidylcholine metabolic process regulation of phospholipid metabolic process regulation of catabolic process negative regulation of phospholipid metabolic process phosphatidylcholine catabolic process negative regulation of phosphatidylcholine metabolic process organophosphate metabolic process regulation of cellular catabolic process negative regulation of phosphorus metabolic process cellular process organic substance catabolic process lipid metabolic process multicellular organismal process very-low-density lipoprotein particle clearance plasma lipoprotein particle clearance regulation of plasma lipoprotein particle levels localization transport macromolecule localization organic substance transport phospholipid transport lipid localization lipid transport establishment of localization organophosphate ester transport phospholipid efflux plasma lipoprotein particle organization protein-containing complex organization protein-containing complex remodeling protein-lipid complex organization plasma lipoprotein particle remodeling cellular component organization protein-lipid complex remodeling cellular component organization or biogenesis organic hydroxy compound metabolic process sterol metabolic process steroid metabolic process cholesterol metabolic process alcohol metabolic process organic cyclic compound metabolic process secondary alcohol metabolic process small molecule metabolic process regulation of localization import into cell regulation of cellular component organization negative regulation of transport negative regulation of endocytosis vesicle-mediated transport regulation of endocytosis negative regulation of cellular component organization negative regulation of receptor-mediated endocytosis regulation of transport regulation of receptor-mediated endocytosis regulation of vesicle-mediated transport endocytosis receptor-mediated endocytosis negative regulation of very-low-density lipoprotein particle clearance negative regulation of lipoprotein particle clearance regulation of lipoprotein particle clearance regulation of multicellular organismal process regulation of very-low-density lipoprotein particle clearance negative regulation of multicellular organismal process negative regulation of sterol transport regulation of lipid transport organic hydroxy compound transport negative regulation of lipid localization sterol transport regulation of cholesterol transport regulation of sterol transport negative regulation of lipid transport negative regulation of cholesterol transport regulation of lipid localization cholesterol transport cholesterol efflux lipoprotein metabolic process protein metabolic process macromolecule metabolic process very-low-density lipoprotein particle assembly cellular component biogenesis cellular component assembly protein-containing complex assembly plasma lipoprotein particle assembly protein-lipid complex assembly high-density lipoprotein particle remodeling neutral lipid metabolic process triglyceride metabolic process acylglycerol metabolic process chylomicron remnant clearance triglyceride-rich lipoprotein particle clearance negative regulation of small molecule metabolic process oxoacid metabolic process organic acid metabolic process organic acid biosynthetic process negative regulation of lipid biosynthetic process carboxylic acid biosynthetic process cellular ketone metabolic process regulation of small molecule metabolic process organic substance biosynthetic process regulation of cellular ketone metabolic process negative regulation of cellular biosynthetic process biosynthetic process regulation of fatty acid metabolic process regulation of fatty acid biosynthetic process monocarboxylic acid metabolic process cellular biosynthetic process lipid biosynthetic process negative regulation of fatty acid biosynthetic process regulation of biosynthetic process fatty acid metabolic process negative regulation of fatty acid metabolic process monocarboxylic acid biosynthetic process small molecule biosynthetic process carboxylic acid metabolic process fatty acid biosynthetic process regulation of cellular biosynthetic process negative regulation of biosynthetic process regulation of lipid biosynthetic process negative regulation of hydrolase activity regulation of catalytic activity negative regulation of lipase activity negative regulation of molecular function negative regulation of catalytic activity regulation of lipoprotein lipase activity negative regulation of lipoprotein lipase activity regulation of molecular function regulation of hydrolase activity regulation of lipase activity	protein-containing complex extracellular region plasma lipoprotein particle high-density lipoprotein particle extracellular space cellular anatomical entity lipoprotein particle protein-lipid complex chylomicron very-low-density lipoprotein particle triglyceride-rich plasma lipoprotein particle membrane-bounded organelle intracellular organelle intracellular anatomical structure protein-containing complex extracellular region plasma lipoprotein particle high-density lipoprotein particle extracellular space cellular anatomical entity lipoprotein particle protein-lipid complex chylomicron very-low-density lipoprotein particle triglyceride-rich plasma lipoprotein particle membrane-bounded organelle intracellular organelle intracellular anatomical structure organelle endoplasmic reticulum cytoplasm intracellular membrane-bounded organelle endomembrane system

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B	IPR043081	Apolipoprotein C-I domain superfamily	Homologous Superfamily
A, B	IPR006781	Apolipoprotein C-I	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B	Pharos: P02654	Alzheimer disease congestive heart failure Heart Failure, Right-Sided invasive ductal breast carcinoma Lewy body dementia lung carcinoma metabolic syndrome X abdominal aortic aneurysm nasopharyngeal carcinoma adrenal cortex carcinoma oligodendroglioma astrocytic tumor vascular dementia cerebrovascular disorder diabetes mellitus Alzheimer disease congestive heart failure Heart Failure, Right-Sided invasive ductal breast carcinoma Lewy body dementia lung carcinoma metabolic syndrome X abdominal aortic aneurysm nasopharyngeal carcinoma adrenal cortex carcinoma oligodendroglioma astrocytic tumor vascular dementia cerebrovascular disorder diabetes mellitus glioblastoma heart disease IgA glomerulonephritis large cell medulloblastoma lung adenocarcinoma malignant glioma acute myeloid leukemia non-alcoholic fatty liver disease age-related macular degeneration psoriasis breast cancer wet macular degeneration chronic obstructive pulmonary disease ductal breast carcinoma in situ head and neck cancer heart failure interstitial cystitis lung cancer malignant mesothelioma myocardial infarction adenoma non-small cell lung carcinoma subependymal giant cell astrocytoma breast carcinoma esophageal adenocarcinoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.